1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Silicon INSITE, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

Boston MA US

Primary Industry

Biotechnology

About

Based in Massachusetts, US, and founded in 2016, Silicon INSITE, Inc. operates as a drug discovery company. The company was co-founded by Lanny Sun, Lijun Sun, and Woody Sherman. In October 2016, Silicon INSITE, Inc. raised its latest series A funding from Chengwei Capital. In February 2021, the company agreed to be acquired by Roivant Sciences, Inc. for USD 450 million. Silicon INSITE, Inc. initial product INSITE is a discovery engine for a computational tool that recapitulates the system dynamics of protein-ligand binding.
Current Investors
Dexcel Pharma Technologies Ltd., Roivant Sciences Ltd.

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.silicontx.com
Verticals
Artificial Intelligence
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.